- Evaluating CMOs for their capabilities to create nanoparticles
- Best techniques for building and maintaining good relationships with CMOs
- Scale- and phase-appropriate approaches to creating a robust clinical supply chain
- Ensuring quality systems work in-line with your expectations for:
- Utilities and facilities
- Environmental monitoring (EM)
- Out of Specification (OOS) results
- Investigation handling
- Producing high quality materials with non-conventional processes